Allison Richards

Nivolumab in Resected and Unresectable Metastatic Melanoma: Characteristics of Immune-Related Adverse Events and Association with Outcomes

Morganna Freeman-Keller, Young‐Chul Kim, Heather Cronin et al. · Clinical Cancer Research · 2015 · 875 citations · Full text

Medicine, Oncology, Pharmacology +17

Safety, Correlative Markers, and Clinical Results of Adjuvant Nivolumab in Combination with Vaccine in Resected High-Risk Metastatic Melanoma

Geoffrey T. Gibney, Ragini R. Kudchadkar, Ronald C. DeConti et al. · Clinical Cancer Research · 2014 · 256 citations · Full text

Medicine, Immunology, Oncology +17

Phase I/II Study of Metastatic Melanoma Patients Treated with Nivolumab Who Had Progressed after Ipilimumab

Jeffrey S. Weber, Geoffrey T. Gibney, Ragini R. Kudchadkar et al. · Cancer Immunology Research · 2016 · 248 citations · Full text

Life Sciences, Oncology, Pharmacotherapy +17

Combination of Ipilimumab and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma

John E. Mullinax, MacLean Hall, Sangeetha Prabhakaran et al. · Frontiers in Oncology · 2018 · 97 citations · Full text

Pharmacy, Immunology, Oncology +17

Self-Esteem and Self-Concept Examination Among Gifted Students With ADHD

Megan Foley‐Nicpon, Heather Rickels, Susan G. Assouline et al. · journal for the education of the gifted · 2012 · 83 citations

Education, Educational Psychology, Psychology +17